Supplementary Table S9
Published: 8 May 2026| Version 1 | DOI: 10.17632/zj87k58nyw.1
Contributor:
Gizem S NemutluDescription
We evaluated three surveillance strategies: (i) no surveillance, (ii) delayed surveillance initiated at progression to compensated cirrhosis (F4), and (iii) immediate surveillance starting at F3. The file reports total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) for all parameter variations across these strategies.
Files
Institutions
- Brandeis UniversityMassachusetts, Waltham
- Mass General BrighamMassachusetts, Boston
Categories
Hepatocellular Carcinoma, Health Outcomes